A major challenge to understanding glaucomatous damage is the lapse between initial structural changes to the optic nerve and the functional changes that follow. OCT often shows RNFL loss when there is not yet any visual field loss. Part of our challenge in making the diagnosis is understanding the correlation between both tests, which is also especially important for progression.1
ZEISS supports complex disease management by integrating critical data points necessary to make accurate decisions on treatment paths and providing at-a-glance history and progression trends with interactive analysis.
Preserving vision requires making the right decisions at the right time; making those decisions with confidence starts with detecting change as early as possible.
ZEISS VISUPLAN 500
The VISUPLAN® 500 does not require contact with the cornea or an anesthetic. Instead, the IOP is measured with a soft puff of air and can be administered by your practice team.
ZEISS SL 800 Slit Lamp
The intuitive SL Imaging Solution from ZEISS takes your everyday slit lamp exams to the next level by adding the integration of high-quality image and video capture to exam reports, offering you the ability to document cases, including patient education, teaching or publishing.
The standard of care tools to diagnose and monitor glaucoma is an OCT and visual field test. Both data points are important to establish a baseline and follow-up trends. Using high-performance devices such as the CIRRUS® and HFA® you will minimize testing time, and maximize information.
ZEISS CIRRUS OCT 6000
The CIRRUS family is built upon the power of dense data cubes, called the densely-layered SmartCube™ technology. Unique to ZEISS, SmartCube analyses using proprietary with normative data, rapidly configure results into diagnostic informative maps, metrics, and visualizations that help you detect glaucoma and clearly identify those patients who’re glaucoma may be are progressing.
ZEISS HFA3 Perimeter
The visual field end-point in hundreds of studies, the HFA has been a part of virtually every major clinical trial in glaucoma for over 20 years. The HFA is the gold standard of perimetry and is a critical diagnostic partner in thousands of practices. Continuing to evolve - today, HFA delivers the interactive analysis you need, when and where you need it.
Managing surgery expectations with patients is critical and using the right surgical care tools will give you the confidence you need to ensure the best outcomes for your patients.
ZEISS ARTEVO 800
The industry’s first digital microscope supports you with improved ergonomics and a reimagined visualization concept to see more.
Easily track, capture and measure progression over time to help you determine if more aggressive therapy is needed.
ZEISS Glaucoma Workplace
Analyze side-by-side progression data from CIRRUS® HD-OCT and HFA® at a glance. The Progression Summary display intelligently configures the Structure-Function Guided Progression Analysis (GPA) to show specifically where progression has been detected.